Runway Healthcare L.P.的动态

?? Moximed secures $91m financing to commercialise its MISHA knee system The new investors, including Cormorant Asset Management and Warren Point Capital, have participated in the financing round, along with existing investors. The existing investors include New Enterprise Associates (NEA), Future Fund, Advent Life Sciences, Gilde Healthcare, Vertex Ventures HC, GBS Venture Partners, and Morgenthaler Ventures. Moximed intends to use the proceeds from the financing round to advance the commercialisation of its MISHA Knee System in the US. Read more online: https://lnkd.in/efXVBGq2 ?? Follow Medical Device Developments to receive the latest medical device news daily and to subscribe to our weekly newsletter #MedicalDeviceDevelopments #medicaldevices #medicalmanufacturing

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value ? We are pleased to announce that Impact BioMedical Inc. (NYSE American: IBO) successfully priced its initial public offering (IPO) yesterday at $3.00 per share, with an offering of 1,500,000 shares. The shares are now trading on the NYSE American Market under the ticker symbol "IBO." ? This significant milestone reflects the innovative contributions of Impact BioMedical and reinforces DSS, Inc. (NYSE American: DSS)’s commitment to advancing healthcare solutions while enhancing shareholder value. The IPO is set to close today, pending customary closing conditions. ? In August 2023, DSS distributed shares of Impact BioMedical to our shareholders, further demonstrating the value we bring to our investors through strategic initiatives. ? https://lnkd.in/eySPbRgk ? #DSS #IPO #HealthcareInnovation #ShareholderValue #InvestmentOpportunities #IBO

Join us at the Beckers ASC Conference to gain critical insights on navigating today's healthcare challenges. From mastering private equity in ASCs and physician investment strategies to overcoming prior authorization obstacles and maximizing profitability don’t miss these key sessions: - Navigating Private Equity in ASCs: Cash In or Sell Out? - Prior Authorization Success: How to Combat Obstacles While Meeting Margins - How to Win with Value-Based Care Today - ASC Ownership, Joint Ventures, Noncompetes & More Secure your tickets today. https://hubs.ly/Q02PhM0M0

DSS, Inc. Celebrates Impact BioMedical Inc.'s Successful IPO and Proudly Advances Shareholder Value ? We are pleased to announce that Impact BioMedical Inc. (NYSE American: IBO) successfully priced its initial public offering (IPO) yesterday at $3.00 per share, with an offering of 1,500,000 shares. The shares are now trading on the NYSE American Market under the ticker symbol "IBO." ? This significant milestone reflects the innovative contributions of Impact BioMedical and reinforces DSS, Inc. (NYSE American: DSS)’s commitment to advancing healthcare solutions while enhancing shareholder value. The IPO is set to close today, pending customary closing conditions. ? In August 2023, DSS distributed shares of Impact BioMedical to our shareholders, further demonstrating the value we bring to our investors through strategic initiatives. ? https://lnkd.in/eP9YHyAM ? #DSS #IPO #HealthcareInnovation #ShareholderValue #InvestmentOpportunities #IBO

?? Big strides for SPRY Therapeutics! The SaaS platform for physical therapy professionals has raised $15 million in a new funding round led by Flourish Ventures, Together Fund, and Fidelity's Eight Roads & F-prime Capital, bringing its total funding to $25 million since its 2021 launch. Co-founded by Brijraj Bhuptani (former CTO of Ola) and Riyaz Rehman, SPRY is transforming clinic management by automating complex billing processes and enhancing patient engagement. With this new funding, SPRY is set to expand further into the US market and continue revolutionizing physical therapy management! ???? #HealthTech #SaaS #Funding #Innovation #SPRY #iAccelerate

Digital MSK is starting to fulfil its potential in 2024, IPO's likely in 2025 https://lnkd.in/eMiMZui5 The digital MSK (musculoskeletal) market is on the rise in 2024. MSK digital health solutions have raised $223M so far this year, already nearly double that of 2023’s $125M. Since 2010, more than $38 Billion has been invested in companies offering MSK solutions, including mergers and acquisitions. An example of a successful digital MSK IPO is Physitrack, which went public in 2021. It's likely that other companies will follow suit in the coming years. Overall, digital MSK is a promising area in healthcare technology, and 2025 could be a big year for IPOs in this space. So who could go public in the next 18 months? Hinge Health: Hinge Health is a digital health company that provides virtual physical therapy and pain management services. The company uses sensors and artificial intelligence to track patients' movements and provide real-time feedback. Sword Health: Sword Health is a digital health company that provides patients with access to physical therapy, pain management, and other services through a mobile app. The company uses sensors and artificial intelligence to track patients' movements and provide real-time feedback. Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit?https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email?[email protected]? HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!?https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit?www.nelsonadvisors.co.uk? https://lnkd.in/eMiMZui5 #HealthTech #DigitalHealth #HealthIT #NelsonAdvisors #Mergers #Acquisitions #Growth #Strategy

We are pleased to confirm that our parent company, 4D Medicine Ltd, has recently completed a ￡3.4m investment deal led by Oshen Holdings and backed by DSW Ventures, SFC Capital, Boundary Capital Partners LLP and a number of private angel investors. The funds are being used to complete the pre-clinical testing of our first medical device products and to prepare for market entry in the US. For more information, see the attached press release. #medicaldevice #medical3dprinting #SeriesA #investment #UKTechInvestmentNews #medtech #innovation

**Artiva Shares Surge 30% Following $167 Million US IPO** Artiva Health, a healthcare technology company, has seen its shares jump 30% after a successful upsized initial public offering (IPO) in the United States. The company raised $167 million in the IPO, exceeding its initial target of $125 million. The company's shares are listed on the Nasdaq stock exchange under the ticker symbol "ARCT." The strong IPO performance suggests investor confidence in Artiva's growth potential and its ability to capitalize on the growing demand for healthcare technology solutions. Artiva's technology platform focuses on improving patient outcomes and reducing healthcare costs by providing advanced analytics and data insights to healthcare providers. The company's solutions are designed to help healthcare providers make more informed decisions and improve patient care. The successful IPO is a significant milestone for Artiva, and the company is well-positioned to continue its growth trajectory in the healthcare technology industry. #ArtivaHealth #IPO #HealthcareTechnology #StockMarket #NASDAQ Source: https://lnkd.in/g2k8tyBC Update Date: 14 hours ago

The benefits of Baby HMO investments: 'juicy' cash flow and capital growth. ???? Learn how to create a winning investment strategy by watching our full discussion on our latest Deal Clinic >> https://lnkd.in/gfUUgAS2 #SourcingInvestments #PropertySourcing #ProperyClinic #InvestmentProperty #HMO #babyhmo

I guess the team Pacific Equity Partners are big fans of Dr Nick from the Simpsons or maybe it’s just defensible assets? In any event it would appear that they are having a good look at Integral Diagnostics (IDX) as part of their second Secure Assets Fund. Integral Diagnostics (IDX) has struggled recently with a market cap of $490m on $89m of EBITDA. Radiology clinics have been somewhat of a darling for private equity presenting defensible assets with high barriers of entry and stable cashflows. It would appear that Pacific Equity Partners team led by Andrew Charlier, Paul Foster and Evan Hattersley are keen to get their teeth stuck into the sector with a possible takeover offer for underperforming Integral Diagnostics (IDX) being a logical entry point. Pacific Equity Partners are arguable the leading private equity firm for public to private transactions having completed a number of them with great success including the most recent of Healthia Limited Australia. I would expect that a deal will be done quickly if the target ticks the boxes for the team at PEP. Certainly plenty of action at the moment in listed and unlisted markets! #privateequity #takeover #mergersandacquisitions #corporateadvisory